South Korea · Delayed Price · Currency is KRW Kwang Dong Pharmaceutical Statistics
Total Valuation
KRX:009290 has a market cap or net worth of KRW 235.72 billion. The enterprise value is 425.28 billion.
| Market Cap | 235.72B |
| Enterprise Value | 425.28B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Mar 31, 2026 |
Share Statistics
KRX:009290 has 36.66 million shares outstanding. The number of shares has increased by 14.97% in one year.
| Current Share Class | 36.66M |
| Shares Outstanding | 36.66M |
| Shares Change (YoY) | +14.97% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | 13.97% |
| Owned by Institutions (%) | 27.18% |
| Float | 29.60M |
Valuation Ratios
The trailing PE ratio is 13.44.
| PE Ratio | 13.44 |
| Forward PE | n/a |
| PS Ratio | 0.14 |
| PB Ratio | 0.33 |
| P/TBV Ratio | 0.41 |
| P/FCF Ratio | 230.64 |
| P/OCF Ratio | 13.33 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.89, with an EV/FCF ratio of 416.11.
| EV / Earnings | 19.49 |
| EV / Sales | 0.25 |
| EV / EBITDA | 8.89 |
| EV / EBIT | 15.56 |
| EV / FCF | 416.11 |
Financial Position
The company has a current ratio of 1.34, with a Debt / Equity ratio of 0.43.
| Current Ratio | 1.34 |
| Quick Ratio | 0.90 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 5.57 |
| Debt / FCF | 294.44 |
| Interest Coverage | 2.95 |
Financial Efficiency
Return on equity (ROE) is 3.46% and return on invested capital (ROIC) is 2.82%.
| Return on Equity (ROE) | 3.46% |
| Return on Assets (ROA) | 1.68% |
| Return on Invested Capital (ROIC) | 2.82% |
| Return on Capital Employed (ROCE) | 4.27% |
| Weighted Average Cost of Capital (WACC) | 4.19% |
| Revenue Per Employee | 1.67B |
| Profits Per Employee | 21.37M |
| Employee Count | 1,021 |
| Asset Turnover | 1.37 |
| Inventory Turnover | 6.78 |
Taxes
In the past 12 months, KRX:009290 has paid 9.97 billion in taxes.
| Income Tax | 9.97B |
| Effective Tax Rate | 30.31% |
Stock Price Statistics
The stock price has increased by +5.93% in the last 52 weeks. The beta is 0.35, so KRX:009290's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +5.93% |
| 50-Day Moving Average | 6,061.20 |
| 200-Day Moving Average | 6,845.25 |
| Relative Strength Index (RSI) | 55.26 |
| Average Volume (20 Days) | 161,846 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:009290 had revenue of KRW 1.71 trillion and earned 21.82 billion in profits. Earnings per share was 478.54.
| Revenue | 1.71T |
| Gross Profit | 311.62B |
| Operating Income | 33.54B |
| Pretax Income | 32.91B |
| Net Income | 21.82B |
| EBITDA | 54.07B |
| EBIT | 33.54B |
| Earnings Per Share (EPS) | 478.54 |
Balance Sheet
The company has 177.70 billion in cash and 300.93 billion in debt, with a net cash position of -123.23 billion or -3,361.34 per share.
| Cash & Cash Equivalents | 177.70B |
| Total Debt | 300.93B |
| Net Cash | -123.23B |
| Net Cash Per Share | -3,361.34 |
| Equity (Book Value) | 705.01B |
| Book Value Per Share | 12,849.91 |
| Working Capital | 178.58B |
Cash Flow
In the last 12 months, operating cash flow was 17.69 billion and capital expenditures -16.66 billion, giving a free cash flow of 1.02 billion.
| Operating Cash Flow | 17.69B |
| Capital Expenditures | -16.66B |
| Depreciation & Amortization | 20.53B |
| Net Borrowing | -14.26B |
| Free Cash Flow | 1.02B |
| FCF Per Share | 27.88 |
Margins
Gross margin is 18.25%, with operating and profit margins of 1.96% and 1.28%.
| Gross Margin | 18.25% |
| Operating Margin | 1.96% |
| Pretax Margin | 1.93% |
| Profit Margin | 1.28% |
| EBITDA Margin | 3.17% |
| EBIT Margin | 1.96% |
| FCF Margin | 0.06% |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 1.67%.
| Dividend Per Share | 100.00 |
| Dividend Yield | 1.67% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 22.76% |
| Buyback Yield | -14.97% |
| Shareholder Yield | -13.30% |
| Earnings Yield | 9.26% |
| FCF Yield | 0.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 26, 1999. It was a forward split with a ratio of 5.
| Last Split Date | Apr 26, 1999 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
KRX:009290 has an Altman Z-Score of 2.37 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.37 |
| Piotroski F-Score | 5 |